Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY.
Department of Emergency Medicine, Albert Einstein College of Medicine, Bronx, NY.
Ann Emerg Med. 2021 Mar;77(3):345-356. doi: 10.1016/j.annemergmed.2020.10.004. Epub 2020 Dec 23.
We compare the efficacy and adverse effects of 5 oral analgesics in emergency department (ED) patients aged 21 to 64 years with acute musculoskeletal pain.
This was a randomized clinical trial conducted in 2 urban EDs. Patients received 400 mg ibuprofen/1,000 mg acetaminophen, 800 mg ibuprofen/1,000 mg acetaminophen, 30 mg codeine/300 mg acetaminophen, 5 mg hydrocodone/300 mg acetaminophen, or 5 mg oxycodone/325 mg acetaminophen. The primary outcome was change in pain before administration of medication (baseline) to 1 hour postbaseline. A numeric rating scale was used, varying from 0="no pain" to 10="worst imaginable pain." Secondary outcomes included receipt of rescue medication and adverse effects at 1 and 2 hours postbaseline. ANOVA was used to test differences in the primary outcome between treatment groups.
Six hundred participants, predominantly men and Latino, were enrolled. Change in pain from baseline to 60 minutes did not differ by treatment (P=.69). The mean change in pain in numeric rating scale units was 400 mg ibuprofen/1,000 mg acetaminophen 3.0 (95% confidence interval [CI] 2.6 to 3.5); 800 mg ibuprofen/1,000 mg acetaminophen 3.0 (95% CI 2.5 to 3.5), 30 mg codeine/300 mg acetaminophen 3.4 (95% CI 2.9 to 3.9), 5 mg hydrocodone/300 mg acetaminophen 3.1 (95% CI 2.7 to 3.5), and 5 mg oxycodone/325 mg acetaminophen 3.3 (95% CI 2.8 to 3.7). Rescue medication was received before 1 hour had elapsed by 2 patients receiving 400 mg ibuprofen/1,000 mg acetaminophen (1.7%), 3 patients receiving 800 mg ibuprofen/1,000 mg acetaminophen (2.5%), zero patients receiving 30 mg codeine/300 mg acetaminophen (0.0%), 3 patients receiving 5 mg hydrocodone/300 mg acetaminophen (2.5%), and zero patients receiving 5 mg oxycodone/325 mg acetaminophen (0.0%) (P=.21). More patients who received opioids were nauseated or vomited compared with those who did not: 6.7% versus 1.7% (5.0% difference; 95% CI 1.7% to 8.2%). The findings at 2 hours were similar.
No analgesic was more efficacious than others 1 or 2 hours after baseline. There was significantly more nausea and vomiting among patients treated with opioids.
我们比较了 21 至 64 岁患有急性肌肉骨骼疼痛的急诊科(ED)患者使用 5 种口服镇痛药的疗效和不良反应。
这是在 2 家城市 ED 进行的一项随机临床试验。患者接受 400 毫克布洛芬/1000 毫克对乙酰氨基酚、800 毫克布洛芬/1000 毫克对乙酰氨基酚、30 毫克可待因/300 毫克对乙酰氨基酚、5 毫克氢可酮/300 毫克对乙酰氨基酚或 5 毫克羟考酮/325 毫克对乙酰氨基酚治疗。主要结局是从用药前(基线)到基线后 1 小时疼痛的变化。使用数字评分量表,范围从 0="无疼痛"到 10="最想象的疼痛"。次要结局包括基线后 1 和 2 小时接受解救药物和不良反应。方差分析用于检验治疗组之间主要结局的差异。
600 名参与者,主要是男性和拉丁裔,入组。从基线到 60 分钟疼痛的变化不因治疗而异(P=.69)。数字评分量表单位疼痛的平均变化为 400 毫克布洛芬/1000 毫克对乙酰氨基酚 3.0(95%置信区间[CI]2.6 至 3.5);800 毫克布洛芬/1000 毫克对乙酰氨基酚 3.0(95%CI 2.5 至 3.5),30 毫克可待因/300 毫克对乙酰氨基酚 3.4(95%CI 2.9 至 3.9),5 毫克氢可酮/300 毫克对乙酰氨基酚 3.1(95%CI 2.7 至 3.5)和 5 毫克羟考酮/325 毫克对乙酰氨基酚 3.3(95%CI 2.8 至 3.7)。在 1 小时前有 2 名接受 400 毫克布洛芬/1000 毫克对乙酰氨基酚治疗的患者(1.7%)、3 名接受 800 毫克布洛芬/1000 毫克对乙酰氨基酚治疗的患者(2.5%)、0 名接受 30 毫克可待因/300 毫克对乙酰氨基酚治疗的患者(0.0%)(0.0%)(P=.21)。与未接受阿片类药物治疗的患者相比,接受阿片类药物治疗的患者出现恶心或呕吐的比例更高:6.7%比 1.7%(5.0%差异;95%CI 1.7%至 8.2%)。2 小时时的发现相似。
基线后 1 或 2 小时,没有一种镇痛药比其他镇痛药更有效。接受阿片类药物治疗的患者恶心和呕吐的发生率明显更高。